I’m not sure if this would be the case, but would they do the dose escalation (phase 1b) at a single site and then conduct the trials at all sites (phase 2)? I’m not sure if that is common or likely, but to me would make sense as it would be easier to manage 18 patients and protocol at a single location rather than 5.